Quartz Bio is a service company specialized in the computational analysis of biomarker data from clinical trials. Quartz Bio is a spin-off of Merck Serono. The capital of the company is entirely owned by its employees.
Quartz Bio is composed of experienced scientists from diverse educational backgrounds such as Cell Biology, Physiology, Physics Computer Science and Mathematics. This diversity in perspectives allows approach biological data analysis under multiple facets and constitutes a primary asset in an scientific exploratory project.
All employees have a track record of 6 to 10 years clinical bioinformatics experience in a pharmaceutical company.
Within this experience Quartz Bio scientists have analysed biomarker data from over 50 clinical studies ranging from Phase I to Phase IV in different therapeutic areas (Oncology, Neurology, Rheumatology, Endocrinology and Fertility).
Quartz Bio technical expertise spans multiple biomaker technological platforms such as: genetics, transcriptomics, protein assays and cellular assays.